Asosiy kontentga oʻtish
Sharh maqola

Nanomedicine-induced pyroptosis for anti-tumor immunotherapy: Mechanism analysis and application prospects

Yuelin HuangShanghai University of Sport, Shanghai 200438, ChinaChunting WangShanghai University of Sport, Shanghai 200438, ChinaYanhong ChenXinHua HospitalDengbin WangDepartment of Radiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, ChinaDefan YaoShanghai University of Sport, Shanghai 200438, China
2025en
ABI

Annotatsiya

Pyroptosis is a new type of programmed cell death that can efficiently enhance the immune response by inducing cell lysis and inflammation, thereby facilitating tumor immunotherapy. Recently, an increasing number of studies have revealed close relationships between pyroptosis and nanomedicine, which has been regarded as a new strategy for developing nanomedicine-based immunotherapy for highly effective therapy of various cancers. In this review, the development and associated signaling pathways for pyroptosis, including the correlation between pyroptosis and anti-tumor immunity, were first presented. Then, various nanomedicines that induce pyroptosis for tumor therapy, especially immunotherapy, were systematically discussed. Finally, the current challenges and constructive perspectives in this field were proposed.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba